Eli Lilly's Zepbound is set to dominate the global obesity market, offering new hope with its groundbreaking treatment for ...

Musk revealed using Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, highlighting their popularity for weight management.

The stock of the pharmaceutical company, Lupin is quoting higher for the sixth straight trading day; it has rallied 10 per ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

FDA approves Zepbound for obstructive sleep apnea in obese individuals Discover how this weight-loss drug reduces symptoms ...

It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.

Discover how Mounjaro the revolutionary weight-loss and diabetes drug by Eli Lilly is set to transform obesity management in ...

The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Is tech billionaire Elon Musk suffering from type 2 diabetes? Musk recently posted a photo of him dressed as a Santa. Musk ...

Imagine if you could eat your fill on Christmas day then dial down your appetite for January. Good news: such a prospect may ...

Eli Lilly has been riding the weight-loss drug ... moderate to severe obstructive sleep apnea, which opens up a new market for the drug. From a valuation perspective, the stock trades at a forward ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).